Cardiac Arrhythmias in Post-COVID Syndrome: Understanding Prevalence, Pathology, and Treatment

A comprehensive review published in ‘Viruses’ journal sheds light on the prevalence, underlying pathologies, and clinical management of cardiac arrhythmias in post-COVID patients. The study highlights the emerging challenge of managing long-term cardiovascular complications in individuals recovering from COVID-19.

Here’s a summary of its key findings:

  1. Prevalence and Symptoms: Post-COVID patients frequently report cardiopulmonary symptoms such as chest pain, shortness of breath, and tachycardia, affecting about one in ten patients. Common cardiovascular complaints include tachycardia, palpitations, and a subjective perception of cardiac arrhythmia, with bradyarrhythmia less commonly reported​​.
  2. Pathogenesis and Underlying Mechanisms: The wide spectrum of cardiac arrhythmias, including supraventricular tachycardias, ventricular tachyarrhythmias, bradyarrhythmias, and conduction defects, arises from various pathomechanisms. These include direct myocardial injury, electric instability, and the hyperinflammatory reaction of the immune system​​.
  3. Direct Cellular Injury: The study discusses the role of the angiotensin-converting enzyme (ACE2) in SARS-CoV-2 infection and its expression in cardiac tissues. It suggests that the virus may indirectly cause myocardial injury through hyperactivation of the immune system, leading to microvascular injury and arrhythmogenic effects​​.
  4. Inflammatory Cytokines: Elevated proinflammatory cytokines, such as TNF-α, IL-1, and IL-6, have been implicated in the pathogenesis of cardiac arrhythmias in COVID-19 patients. These cytokines can cause direct cardiac changes and systemic alterations, leading to arrhythmogenic damage​​.
  5. Indirect Arrhythmogenic Effects: Systemic disturbances such as inhibition of the hepatic cytochrome P450 system, hormonal changes, and fever-related effects on the nervous system can contribute to arrhythmogenic effects​​.
  6. Specific Arrhythmias: Postural Orthostatic Tachycardia Syndrome (POTS) and Inappropriate Sinus Tachycardia Syndrome (IST) are among the common autonomic disorders observed in post-COVID patients. POTS is often associated with immunological stressors and exhibits symptoms like tachycardia and orthostatic intolerance. IST is more common in young women and is associated with palpitations and increased heart rate​​.
  7. Atrial Fibrillation (AF): AF is a common cardiovascular disorder in post-COVID patients, associated with increased mortality rates. The study suggests that myocardial lesions associated with AF in post-COVID patients could be due to hypercoagulability, persistent hyperinflammation, and other myocardial injuries​​.
  8. Vaccination-Associated Arrhythmias: Cardiovascular complications, including myocarditis and various arrhythmias, have been reported after mRNA-based COVID-19 vaccination, especially among younger individuals. These complications are rare but significant and require attention​​.
  9. Conclusions and Future Directions: The study emphasizes the need for a multidisciplinary approach to understand and manage the broad spectrum of post-COVID-19 conditions, including cardiac arrhythmias. It highlights the importance of cardiac arrhythmia screening in symptomatic patients and calls for future research to develop evidence-based recommendations for post-COVID patients​​.

In essence, this review provides crucial insights into the cardiac implications of COVID-19, underscoring the importance of comprehensive cardiovascular assessment and management in the post-COVID era.

Read More: https://www.mdpi.com/1999-4915/15/2/389

Leave a comment